Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Ahrendt

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2002
Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective studySteven A Ahrendt, Stephen C Yang, Li Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancerMohammad Obaidul Hoque, Mariana Brait, Eli Rosenbaum, et al.
International Urology and Nephrology|September 16, 2025
Clinical outcomes of urologic reconstruction during cytoreductive surgery with HIPEC: a 13-year single-center experienceDyvon T Walker, Hunter A Flores, Rohan G Bhalla, et al.
Journal of the Advanced Practitioner in Oncology|August 1, 2022
Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic TumorKristen Oase, Meguid Cheryl, Atsushi Oba, et al.
Scientific Reports|August 29, 2015
An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulationShahnaz Begum, Masamichi Hayashi, Takenori Ogawa, et al.
Journal of Surgical Oncology|February 7, 2013
Aggressive locoregional management of recurrent peritoneal sarcomatosisJoel M Baumgartner, Steven A Ahrendt, James F Pingpank, et al.
Annals of Surgical Oncology|July 13, 2016
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell CarcinoidsMichal Radomski, Reetesh K Pai, Yongli Shuai, et al.
Annals of Surgical Oncology|April 7, 2026
A Retrospective Examination of Neoadjuvant Chemotherapy for Metachronous Colorectal Peritoneal Metastases Prior to CRS/HIPECMichael M Wach, Hannah Bank, Kathrine Kelly, et al.
Cancer Medicine|December 29, 2016
Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignanciesMashaal Dhir, Haroon A Choudry, Matthew P Holtzman, et al.
Annals of Surgical Oncology|May 23, 2024
Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent ChemotherapyElliott J Yee, Robert J Torphy, Otto N Thielen, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2002
Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective studySteven A Ahrendt, Stephen C Yang, Li Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancerMohammad Obaidul Hoque, Mariana Brait, Eli Rosenbaum, et al.
International Urology and Nephrology|September 16, 2025
Clinical outcomes of urologic reconstruction during cytoreductive surgery with HIPEC: a 13-year single-center experienceDyvon T Walker, Hunter A Flores, Rohan G Bhalla, et al.
Journal of the Advanced Practitioner in Oncology|August 1, 2022
Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic TumorKristen Oase, Meguid Cheryl, Atsushi Oba, et al.
Scientific Reports|August 29, 2015
An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulationShahnaz Begum, Masamichi Hayashi, Takenori Ogawa, et al.
Journal of Surgical Oncology|February 7, 2013
Aggressive locoregional management of recurrent peritoneal sarcomatosisJoel M Baumgartner, Steven A Ahrendt, James F Pingpank, et al.
Annals of Surgical Oncology|July 13, 2016
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell CarcinoidsMichal Radomski, Reetesh K Pai, Yongli Shuai, et al.
Annals of Surgical Oncology|April 7, 2026
A Retrospective Examination of Neoadjuvant Chemotherapy for Metachronous Colorectal Peritoneal Metastases Prior to CRS/HIPECMichael M Wach, Hannah Bank, Kathrine Kelly, et al.
Cancer Medicine|December 29, 2016
Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignanciesMashaal Dhir, Haroon A Choudry, Matthew P Holtzman, et al.
Annals of Surgical Oncology|May 23, 2024
Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent ChemotherapyElliott J Yee, Robert J Torphy, Otto N Thielen, et al.
Pageof 5